We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against other ...

One of the FDA’s recently departed top officials is ... though all signs point to it being Peter Marks, M.D., Ph.D., who announced his departure as head of the CBER in late March.

Peter Marks’s departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas. First the vaccine approvals and the ...

Senior Correspondent Dr. Peter Marks is the kind of health official both Democrats and Republicans used to admire. He served in the U.S. Food and Drug Administration (FDA) for 13 years ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Key leadership departures—like former FDA Chief Medical Officer Hilary Marston, M.D., and the agency’s former Center for Biologics Evaluation and Research director Peter Marks, M.D., Ph.D ...

For a view on that, I'm joined now by Dr. Peter Marks. Dr. Marks was the top vaccine regulator at the Food and Drug Administration until last month when he was forced out after clashing with Kennedy.

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Erasca Inc. (NASDAQ:ERAS) stands against ...

Dr Peter Marks, who has been director of the FDA's Centre for Biologics Evaluation and Research (CBER) since 2016. The abrupt departure of Peter Marks as the director of the FDA's Centre for ...